EFFECTS OF ACUTE AND CHRONIC ADMINISTRATION OF METHYLMALONIC AND PROPIONIC ACIDS ON THE IN-VITRO INCORPORATION OF P-32 INTO CYTOSKELETAL PROTEINS FROM CEREBRAL-CORTEX OF YOUNG-RATS
A. Demattosdutra et al., EFFECTS OF ACUTE AND CHRONIC ADMINISTRATION OF METHYLMALONIC AND PROPIONIC ACIDS ON THE IN-VITRO INCORPORATION OF P-32 INTO CYTOSKELETAL PROTEINS FROM CEREBRAL-CORTEX OF YOUNG-RATS, Neurochemistry international, 33(1), 1998, pp. 75-82
We studied the effects of acute and chronic administration of methylma
lonic (MMA) and propionic (PA) acids on the in vitro incorporation of
P-32 into neurofilament subunits (NF-M and NF-L), alpha and beta tubul
ins, from cerebral cortex of rats. In the chronic treatment, drugs wer
e administered subcutaneously from day 6-17 post-partum (MMA 0.76-0.89
mu mol/g body weight and PA 0.93 mu mol/g body weight). In the acute
treatment MMA and PA were injected (MMA 3.78 mu mol/g body weight and
PA 3.90 mu mol/g body weight). Control animals received saline in the
same volumes. The Triton-insoluble cytoskeletal fraction of control in
treated animals was isolated and incubated with P-32-ATP. Our results
demonstrate that both drugs were able to inhibit 32P in vitro incorpo
ration into neurofilaments and tubulins. The acute administration of M
MA decreased the in vitro 32P incorporation into NF-L and a-tubulin su
bunit, whereas PA administration decreased the 32P in vitro incorporat
ion into NF-M, NF-L, and tubulins. On the other hand, chronic MMA admi
nistration induced a decreased 32P in vitro incorporation into NF-M, w
hile chronic treatment with propionate decreased the in vitro phosphor
ylation of NF-M and a-tubulin. This study provides consistent evidence
that a decreased phosphorylation of cytoskeletal proteins is induced
by MMA and PA metabolites which accumulate in methylmalonic and propio
nic acidemias respectively. Therefore, it is possible that an altered
brain cytoskeletal metabolism could be related with the structural alt
erations of CNS observed in these disorders. (C) 1998 Elsevier Science
Ltd. All rights reserved.